Status:
COMPLETED
Studies of Sulfur Metabolism in Humans
Lead Sponsor:
Albert Einstein College of Medicine
Conditions:
Metabolic Side Effects of Drugs
Eligibility:
MALE
61-61 years
Phase:
EARLY_PHASE1
Brief Summary
The study test whether the NSAID allosteric site of human sulfotransferase 1A1 (SULT1A1) is operative in humans. The study will test the effects of mefenamic acid (MEF) on the sulfonation of acetamino...
Detailed Description
No patient registries associated with this study. A single, therapeutic dose of acetaminophen (APAP, 1.0 g)) or dehydroepiandrosterone (DHEA, 75 mg) is taken orally (with 375 ml of water) either alon...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- Gender - one male
- Age - 61 y.o.
- Healthy
- Agreed to sign the consent form
- Exclusion criteria:
- ● None
Exclusion
Key Trial Info
Start Date :
January 11 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 2 2023
Estimated Enrollment :
1 Patients enrolled
Trial Details
Trial ID
NCT03383133
Start Date
January 11 2018
End Date
February 2 2023
Last Update
October 27 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Albert Einstein Collage of Medicine
The Bronx, New York, United States, 10461